Find a Doctor

FC
Areas of Expertise

Fred K. Chen

University Of Western Australia
Male

Bio

Fred Chen is in Nedlands, Australia. They have been an author on 143 peer reviewed articles and participated in 1 clinical trial in the past 15 years.

Areas of Expertise

Contact

Nedlands, WA, AU

Latest Research

Latest Advance
Study
  • Condition: Malignant Pleural Mesothelioma (MPM)
  • Journal: Lung cancer (Amsterdam, Netherlands)
  • Treatment Used: Single Oral FGF Inhibitor, AZD4547 as Second or Third Line Therapy
  • Number of Patients: 55
  • Published —
This study assessed the effectiveness of AZD4547, an oral tyrosine multi-kinase FGFR 1-3 inhibitor, as a second or third-line treatment in patients with malignant pleural mesothelioma (MPM) who relapse after treatment with first-line chemotherapy.
Latest Advance
Study
  • Condition: Central Retinal Vein Occlusion
  • Journal: JAMA ophthalmology
  • Treatment Used: Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab ALone
  • Number of Patients: 58
  • Published —
The study compared ranibizumab plus laser-induced chorioretinal anastomosis vs ranibizumab alone in treating central retinal vein occlusion.
Latest Advance
Study
  • Condition: Age-Related Macular Degeneration (AMD)
  • Journal: Ophthalmology
  • Treatment Used: Sub-Threshold Nanosecond Laser (SNL) Intervention
  • Number of Patients: 292
  • Published —
This study evaluated the safety of sub-threshold nanosecond laser (SNL) treatment in intermediate age-related macular degeneration (iAMD) and its effectiveness for slowing progression to late age-related macular degeneration.

Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 600
  • Start Date: October 5, 2017
Single Site, Randomized, Double Blind, Placebo-Controlled Study to Assess the Long-Term Safety of Tafenoquine

All Publications
View All

Publication
Study
  • Journal: Stem cell research
  • Published —
Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene.
Publication
Study
  • Journal: Ophthalmic genetics
  • Published —
Progressive sector retinitis pigmentosa due to c.440G>T mutation in SAG in an Australian family.

Contact

Nedlands, WA, AU

Insurance

Contact them to find out if they accept your insurance plan.